glp-1 drugs depression Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study New study confirms GLP-1 medications
Description
Grasset E, Puel A, Charpentier J, et al
The 2024 joint scientific statement on nutrition and GLP-1 medications recommends involving a registered dietitian where appropriate, especially for people at risk of inadequate nutrient intake or muscle loss
Whereas, the obesity segment will expand at a significant CAGR, with the raised adoption of GLP-1 receptor agonist along with its possession of dual action are fueling the overall market growth
This is a common misconception
consequently, the latter induces negative feedback on the HPG axis, leading to sub-fecundity and infertility
